The Single-Cell Sequencing Market was valued at USD 2,109.8 million in 2023 and is projected to reach USD 7,420.8 million by 2032, registering a CAGR of 15% from 2024 to 2032. The rapid growth of this market is fueled by increasing adoption of single-cell sequencing technologies in biomedical research, precision medicine, and drug discovery. As scientists...